127 related articles for article (PubMed ID: 6159323)
41. Pharmacokinetics of hydroxyethyl starch in normal subjects.
Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
[TBL] [Abstract][Full Text] [Related]
42. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
[TBL] [Abstract][Full Text] [Related]
43. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
Mishler JM
Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
[TBL] [Abstract][Full Text] [Related]
44. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
45. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
[TBL] [Abstract][Full Text] [Related]
46. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
Mishler JM; Parry ES; Sutherland BA; Bushrod JR
Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
[TBL] [Abstract][Full Text] [Related]
47. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
[TBL] [Abstract][Full Text] [Related]
48. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
Mishler JM; Ricketts CR; Parkhouse EJ
Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
[TBL] [Abstract][Full Text] [Related]
49. [Polish hydroxyethyl starch preparation: a clinical study].
Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
[TBL] [Abstract][Full Text] [Related]
50. Hydroxyethyl starch.
Thompson WL
Dev Biol Stand; 1980; 48():259-66. PubMed ID: 6168505
[TBL] [Abstract][Full Text] [Related]
51. [Use of hydroxyethyl starch as a cryoprotective medium during platelet storage at low temperatures].
Kotelba-Witkowska B; Gryszkiewicz A
Acta Haematol Pol; 1975; 6(4):293-7. PubMed ID: 53981
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%).
Degrémont AC; Ismaïl M; Arthaud M; Oulare B; Mundler O; Paris M; Baron JF
Intensive Care Med; 1995 Jul; 21(7):577-83. PubMed ID: 7593900
[TBL] [Abstract][Full Text] [Related]
53. Effect of hydroxyethyl starch on the structure of thrombin- and reptilase-induced fibrin gels.
Carr ME
J Lab Clin Med; 1986 Dec; 108(6):556-61. PubMed ID: 2431085
[TBL] [Abstract][Full Text] [Related]
54. [Erythrocyte freezing in the presence of hydroxyethyl starch].
Daszyński J; Gryszkiewicz A; Kościelak J
Acta Haematol Pol; 1976; 7(2):155-61. PubMed ID: 59513
[TBL] [Abstract][Full Text] [Related]
55. Hydroxyethyl starch. Control of alpha-amylase hydrolysis and its subsequent clinical application.
Mishler JM
Acta Haematol Pol; 1980; 11(2):113-6. PubMed ID: 6158825
[No Abstract] [Full Text] [Related]
56. [Effect of hydroxyethyl starch, oxypolygelatin and human albumin on the phagocytic function of the reticuloendothelial system in healthy subjects].
Lenz G; Hempel V; Junger H; Werle H; Buckenmaier P
Anaesthesist; 1986 Jul; 35(7):423-8. PubMed ID: 2428269
[TBL] [Abstract][Full Text] [Related]
57. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
[TBL] [Abstract][Full Text] [Related]
58. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
Mishler JM; Parry ES
Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
[TBL] [Abstract][Full Text] [Related]
59. [Volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Aug; 5(4):237-8. PubMed ID: 79556
[No Abstract] [Full Text] [Related]
60. Hydroxyethyl starch-induced macroamylasemia.
Köhler H; Kirch W; Horstmann HJ
Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):428-31. PubMed ID: 72048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
